NCT04358796

Brief Summary

The aim of the current study was to examine the effect of short-term HBOT (hyperbaric oxygen treatments) on a range of cognitive abilities. The current study examined whether there is a HBOT-related short-term cognitive improvement and, if so, what specific cognitive abilities are improved by the intervention. Participants were randomized to perform cognitive tasks in one of two chambers with two different clinical environments: (a) HBOT condition: (2 ATA (atmosphere absolute) 100% oxygen for 90 minutes). (b) Control condition: in which the chamber was not pressurized (Normobaric condition- 1 ATA for 90 minutes).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2018

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

February 9, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 24, 2020

Completed
Last Updated

April 24, 2020

Status Verified

April 1, 2020

Enrollment Period

12 months

First QC Date

February 9, 2020

Last Update Submit

April 21, 2020

Conditions

Keywords

Cognitive enhancementMemoryInformation processing speedHyperbaric oxygen treatments

Outcome Measures

Primary Outcomes (6)

  • memory

    Number of words retrieved from a list

    after 20 minutes of intervention

  • Working memory

    accuracy rates on a working memory paradigm (n-back)

    after 20 minutes of intervention

  • Divided attention

    accuracy rates on a divided attention task (identifying visual and auditory targets)

    after 20 minutes of intervention

  • Information processing speed

    Accuracy rates on an information processing speed task (Symbol tracing task)

    after 20 minutes of intervention

  • Response inhibition

    Accuracy rates on a response inhibition task (stroop)

    after 20 minutes of intervention

  • Problem solving

    accuracy rates on a problem solving task (solving arithmetic series)

    after 20 minutes of intervention

Study Arms (2)

HBOT environment

EXPERIMENTAL

Cognitive testing in 2ATA, 100% oxygen in breathing-masks

Device: Hyperbaric oxygent treatment

Control environment

SHAM COMPARATOR

Cognitive testing in 1ATA, air in breathing-masks

Device: Control hyperbaric oxygen treatment

Interventions

Subjects will enter the oxygen chamber. ATA will be elevated to 2 ATA. They will breath 100% oxygen while solving cognitive tests designed to assess their cognitive capacities

HBOT environment

Subjects will enter the oxygen chamber. ATA will be elevated to 1.2 ATA for a short while and the decreased back to 1 ATA. They will breath air while solving cognitive tests designed to assess their cognitive capacities

Control environment

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 20-40
  • intact sight / corrected sight
  • Hebrew as mother tongue
  • Intact comprehension

You may not qualify if:

  • Active neurologic or psychiatric diagnosis.
  • Chest pathology ;
  • Inner ear disease;
  • Claustrophobia;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf Harofeh Medical Center

Ẕerifin, Israel

Location

Study Officials

  • Shay Efrati

    Assaf-Harofeh Medical Center

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients are unaware to the ATA in chamber and to oxygen levels in their mask.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: two groups being tested in parallel. The first group in HBOT environment. The second group in a SHAM environment.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director of the Sagol Center for Hyperbaric Medicine

Study Record Dates

First Submitted

February 9, 2020

First Posted

April 24, 2020

Study Start

November 10, 2017

Primary Completion

November 2, 2018

Study Completion

November 2, 2018

Last Updated

April 24, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations